Renaissance Technologies’s Cytek Biosciences CTKB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.61M | Buy |
1,063,139
+375,539
| +55% | +$1.28M | ﹤0.01% | 1728 |
|
|
2025
Q1 | $2.76M | Buy |
687,600
+225,000
| +49% | +$902K | ﹤0.01% | 1795 |
|
|
2024
Q4 | $3M | Buy |
462,600
+251,000
| +119% | +$1.63M | ﹤0.01% | 1772 |
|
|
2024
Q3 | $1.17M | Sell |
211,600
-22,300
| -10% | -$124K | ﹤0.01% | 2344 |
|
|
2024
Q2 | $1.31M | Buy |
+233,900
| New | +$1.31M | ﹤0.01% | 2164 |
|
|
2023
Q4 | – | Sell |
-296,900
| Closed | -$1.64M | – | 3797 |
|
|
2023
Q3 | $1.64M | Buy |
+296,900
| New | +$1.64M | ﹤0.01% | 1978 |
|
|
2023
Q2 | – | Sell |
-353,500
| Closed | -$3.25M | – | 3980 |
|
|
2023
Q1 | $3.25M | Sell |
353,500
-38,300
| -10% | -$352K | ﹤0.01% | 1730 |
|
|
2022
Q4 | $4M | Buy |
391,800
+179,900
| +85% | +$1.84M | 0.01% | 1651 |
|
|
2022
Q3 | $3.12M | Buy |
211,900
+49,000
| +30% | +$721K | ﹤0.01% | 1736 |
|
|
2022
Q2 | $1.75M | Buy |
162,900
+108,600
| +200% | +$1.17M | ﹤0.01% | 2291 |
|
|
2022
Q1 | $585K | Sell |
54,300
-54,700
| -50% | -$589K | ﹤0.01% | 3092 |
|
|
2021
Q4 | $1.78M | Buy |
+109,000
| New | +$1.78M | ﹤0.01% | 2237 |
|